Oxaliplatin Teva

Oxaliplatin, the active ingredient in Oxaliplatin Teva, is a platinum‑based chemotherapy agent presented as a sterile solution for intravenous infusion use. It is employed in the treatment of colorectal cancer, often in combination with other chemotherapeutic agents, and is administered to adult patients.

GNH USA supplies Oxaliplatin Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Oxaliplatin Teva is a platinum‑based chemotherapeutic that interferes with DNA replication across several gastro‑intestinal malignancies.

- Colorectal cancer: improves the overall response rate when used with 5‑FU/LV. - Gastric cancer: used as part of a multimodal treatment regimen to shrink tumours pre‑operatively. - Pancreatic but    --- - Pan‑        t

Oxaliplatin may ​  

{"error":"Could not parse  "}